EUVIMEDEUVIMED entdecken
Crossref

Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer

Ana Blanca, Antonio Lopez-Beltran, Enrique Gomez-Gomez, Pablo Campos-Hernández, Alessia Cimadamore, Rodolfo Montironi, Liang Cheng

Pathobiology · 26.02.2025 · 92 (4) · 202-215

DOI: 10.1159/000544733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathobiology, online erschienen am 26.02.2025. Verfasst von Ana Blanca und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphological Sciences, University of Cordoba Medical School, Cordoba, Spain. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Receptor, Fibroblast Growth Factor, Type 3, B7-H1 Antigen, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to evaluate the prognostic significance of programmed cell death (PD)-1/PD-ligand 1 (PD-L1), PD-ligand 2 (PD-L2), and fibroblast growth factor receptor 3 (FGFR3) expression in bladder cancer (BC).

Methods

A retrospective study was conducted on BC patients who underwent transurethral resection between 2005 and 2014. Of the initial 136 patients, 31 were excluded for not meeting the inclusion criteria, leaving 105 cases for the final analysis. The mRNA levels of PD-1/PD-L1/PD-L2 and FGFR3 were assessed using quantitative reverse transcription PCR and NanoString technology.

Results

High expression of PD-1 and its ligands (PD-L1/PD-L2) showed a strong correlation with each other and was associated with poor clinical outcomes, including higher tumor stage, grade, and cancer-specific mortality (p < 0.001). Conversely, high FGFR3 expression was associated with improved survival and more favorable clinicopathological features. Interestingly, an inverse relationship was observed between FGFR3 and PD-1 (p = 0.032) and PD-L1 (p = 0.016) expression. High mRNA expression profiles of PD-1, PD-L1, PD-L2, and low FGFR3 expression were associated with worse cancer-specific survival (p < 0.001). Multivariate analysis revealed that advanced stage, low FGFR3 expression, and high PD-L2 expression are independent predictors of poor prognosis in BC patients.

Conclusion

Our findings suggest that elevated levels of PD-1, PD-L1, and PD-L2, combined with reduced FGFR3 expression, may assist in identifying patients with poor outcomes and highlight their potential as prognostic biomarkers in BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsReceptor, Fibroblast Growth Factor, Type 3B7-H1 AntigenProgrammed Cell Death 1 ReceptorProgrammed Cell Death 1 Ligand 2 ProteinHumansMaleFemalePrognosisAgedRetrospective StudiesMiddle AgedRNA, MessengerBiomarkers, TumorAged, 80 and overAdult

Stichwörter der Autor:innen

Bladder cancerFibroblast growth factor receptor 3Prognostic significanceProgrammed cell death-1Programmed cell death-ligand 1/programmed cell death-ligand 2Therapeutic strategy

Substanzen

Receptor, Fibroblast Growth Factor, Type 3B7-H1 AntigenProgrammed Cell Death 1 ReceptorProgrammed Cell Death 1 Ligand 2 ProteinFGFR3 protein, humanRNA, MessengerCD274 protein, humanPDCD1 protein, humanBiomarkers, TumorPDCD1LG2 protein, human

Autor:innen und Institutionen

  • Department of Morphological Sciences, University of Cordoba Medical School, Cordoba, Spain.
  • Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain.
  • Urology Department, Reina Sofia University Hospital, UCO, IMIBIC, Cordoba, Spain.
  • Institute of Pathological Anatomy, Department of Medical Area (DAME), University of Udine, Udine, Italy.
  • Molecular Medicine and Cell Therapy Foundation, c/o Polytechnic University of Marche Region, Ancona, Italy.
  • Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Lifespan Academic Medical Center, and the Legorreta Cancer Center at Brown University, Providence, Rhode Island, USA.

Zitieren

APA

Blanca, A., Lopez-Beltran, A., Gomez-Gomez, E., Campos-Hernández, P., Cimadamore, A., Montironi, R., & Cheng, L. (2025). Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer. Pathobiology, 92(4), 202-215. https://doi.org/10.1159/000544733

Vancouver

Blanca A, Lopez-Beltran A, Gomez-Gomez E, Campos-Hernández P, Cimadamore A, Montironi R, et al. Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer. Pathobiology. 2025;92(4):202-215. doi:10.1159/000544733

BibTeX
@article{Blanca2025,
  author = {Blanca, Ana and Lopez-Beltran, Antonio and Gomez-Gomez, Enrique and Campos-Hernández, Pablo and Cimadamore, Alessia and Montironi, Rodolfo and Cheng, Liang},
  title = {Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer},
  journal = {Pathobiology},
  year = {2025},
  volume = {92},
  number = {4},
  pages = {202--215},
  doi = {10.1159/000544733}
}
Kostenlos starten →